On September 25, the House passed by voice vote the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI) of 2018. The bill updates the PAHPA framework to address 21st century public health threats including the spread of infectious diseases or chemical, biological, radiological or nuclear attacks. The bill would authorize $7.1 billion for the period from fiscal 2019 through 2028 for the Project BioShield special reserve fund used to purchase medical countermeasures.
The bill also would reauthorize the following amounts annually through fiscal year (FY) 2023:
- $685 million for Public Health Emergency Preparedness cooperative agreements with states.
- $611.7 million for ASPR’s Biomedical Advanced Research and Development Authority (BARDA).
- $610 million for the strategic national stockpile of medical countermeasures.
- $385 million for the Hospital Preparedness Program.
- $161.8 million to support CDC biosurveillance and situational awareness activities.
- $100 million for CDC grants to states to prevent and control mosquito-borne diseases.
- $57.4 million for the National Disaster Medical System.
- $40 million for the CDC’s Epidemiology and Laboratory Capacity grant program, the same amount it receives in fiscal 2018.
- $30.8 million for CDC vaccine tracking and distribution activities.
- $11.2 million for the Volunteer Medical Reserve Corps.
- $5 million for an emergency system for advance registration of health professional volunteers.
The Senate passed a similar bill (S. 2852) out of committee in June, but with authorities expiring September 30, 2018, there is a sense of urgency. The House and Senate are expected to reconvene in Washington following the election for a lame duck session around November 13th.